CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 27 enrolled
Drug / intervention
ClariFix devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02820597
NCT02820597N/ACompleted

Clinical Evaluation of Cryotherapy in the Nasal Passageway Using the ClariFix Device

Arrinex, Inc.·interventional·Posted Jul 1, 2016·Updated Oct 21, 2019

In Brief

A clinical study evaluating ClariFix device for Rhinitis. Completed, enrolled 27 participants.

Detailed Summary

This is a single-arm pilot study designed to evaluate the feasibility of cryoablation in the nasal passageway, using the ClariFix device, to reduce the symptoms of chronic rhinitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRhinitis
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 1, 2016
Enrollment StartJun 15, 2015
Primary CompletionFeb 5, 2016
Study CompletionJul 20, 2016
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 10.0 years ago

Interventions

ClariFix devicedevice